{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:59:47Z","timestamp":1782331187331,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,1,4]],"date-time":"2008-01-04T00:00:00Z","timestamp":1199404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11154-007-9071-z","type":"journal-article","created":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T10:37:05Z","timestamp":1199356625000},"page":"131-137","source":"Crossref","is-referenced-by-count":18,"title":["Mineral metabolism and bone abnormalities in children with chronic renal failure"],"prefix":"10.1007","volume":"9","author":[{"given":"Cheryl P.","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,4]]},"reference":[{"issue":"6","key":"9071_CR1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00467-006-0040-7","volume":"21","author":"M Seikaly","year":"2006","unstructured":"Seikaly M, Salhab N, Gipson D, Yiu V, Stablein D. stature in children with chronic kidney disease: Analysis of NAPRCTS database. Pediatr Nephrol. 2006;21(6):793\u20139.","journal-title":"Pediatr Nephrol."},{"issue":"suppl 7","key":"9071_CR2","first-page":"176","volume":"22","author":"M Lewis","year":"2007","unstructured":"Lewis M, Shaw J, Reid C, Evans J, Webb N, Verrier-Jones K. Growth in children with established renal failure a registry analysis. Nephrol Dial Transplant. 2007;22(suppl 7):176\u201380.","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"9071_CR3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/ajkd.2000.17674","volume":"36","author":"C Wong","year":"2000","unstructured":"Wong C, Gipson D, Gillen D, Emerson S, Koepsell T, Sherrard D, et al. Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis. 2000;36(4):811\u20139.","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"9071_CR4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00467-002-0838-x","volume":"17","author":"SL Furth","year":"2002","unstructured":"Furth SL, Hwang W, Yang C, Neu A, Fivush B, Powe N. Growth Failure, Risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol. 2002;17(6):450\u20135.","journal-title":"Pediatr Nephrol."},{"key":"9071_CR5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00874014","volume":"6","author":"J Rosenkranz","year":"1992","unstructured":"Rosenkranz J, Bonzel K-E, Bulla M, Michalk D, Offner G, Reichwald-Klugger E, et al. Psychosocial adaptation of children and adolescents with chronic renal failure. Pediatr Nephrol. 1992;6:459\u201363.","journal-title":"Pediatr Nephrol."},{"issue":"11","key":"9071_CR6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Cunningham J, Goodman WG, Martin K, Olgaard K, Ott S, et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945\u201353.","journal-title":"Kidney Int."},{"issue":"4","key":"9071_CR7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0272-6386(96)90473-4","volume":"28","author":"M Denda","year":"1996","unstructured":"Denda M, Finch J, Slatopolsky E. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis. 1996;28(4):596\u2013602.","journal-title":"Am J Kidney Dis."},{"key":"9071_CR8","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","volume":"73","author":"AA Portale","year":"1984","unstructured":"Portale AA, Booth BE, Halloran BP, Morris RC. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984;73:1580\u20139.","journal-title":"J Clin Invest"},{"issue":"6","key":"9071_CR9","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1046\/j.1523-1755.2001.00042.x","volume":"60","author":"M Cozzolino","year":"2001","unstructured":"Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS. p21waf1 and TGF-Mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int. 2001;60(6):2109\u201317.","journal-title":"Kidney Int."},{"issue":"4","key":"9071_CR10","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1523-1755.2002.kid585.x","volume":"62","author":"M Tokumoto","year":"2002","unstructured":"Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism. Kidney Int. 2002;62(4):1196\u2013207.","journal-title":"Kidney Int."},{"issue":"4","key":"9071_CR11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis. 1998;31(4):607\u201317.","journal-title":"Am J Kidney Dis."},{"issue":"9","key":"9071_CR12","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1681\/ASN.2005030291","volume":"16","author":"MM Mitsnefes","year":"2005","unstructured":"Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: Role of calcium-phosphorus metabolism. J Am Soc Nephrol. 2005;16(9):2796\u2013803.","journal-title":"J Am Soc Nephrol."},{"key":"9071_CR13","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","volume":"96","author":"T Naveh-Many","year":"1995","unstructured":"Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats. J Clin Invest. 1995;96:1786\u201393.","journal-title":"J Clin Invest."},{"key":"9071_CR14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF00866787","volume":"10","author":"KH Marks","year":"1996","unstructured":"Marks KH, Kilav R, Naveh-Many T, Silver J. Calcium, phosphate, vitamin D, and the parathyroid. Pediatr Nephrol. 1996;10:364\u20137.","journal-title":"Pediatr Nephrol."},{"issue":"5","key":"9071_CR15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","volume":"67","author":"TO Pitts","year":"1988","unstructured":"Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, et al. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab. 1988;67(5):876\u201381.","journal-title":"J Clin Endocrinol Metab."},{"key":"9071_CR16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/ki.1982.70","volume":"21","author":"AA Portale","year":"1982","unstructured":"Portale AA, Booth BE, Tsai HC, Morris RC. Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency. Kidney Int. 1982;21:627\u201332.","journal-title":"Kidney Int."},{"issue":"1","key":"9071_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","volume":"50","author":"Z Al-Aly","year":"2007","unstructured":"Al-Aly Z, Qazi R, Gonzalez E, Zeringue A, Martin KJ. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis. 2007;50(1):59\u201368.","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"9071_CR18","first-page":"2169","volume":"10","author":"A Ghazali","year":"1999","unstructured":"Ghazali A, Fardellone P, Pruna A, Atik A, Achard J-M, Oprisiu R, et al. Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and looser\u2019s zones? J Am Soc Nephrol. 1999;10(6):2169\u201377.","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"9071_CR19","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1359\/jbmr.060803","volume":"21","author":"G Elder","year":"2006","unstructured":"Elder G, Mackun K. 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J Bone Miner Res. 2006;21(11):1778\u201384.","journal-title":"J Bone Miner Res."},{"issue":"4 Suppl 1","key":"9071_CR20","first-page":"S1","volume":"46","author":"NKF","year":"2005","unstructured":"NKF. K\/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis. 2005;46(4 Suppl 1):S1\u2013S121.","journal-title":"Am J Kidney Dis."},{"issue":"Supplement 3","key":"9071_CR21","first-page":"S1","volume":"42","author":"NKF","year":"2003","unstructured":"NKF. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(Supplement 3):S1\u2013S201.","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"9071_CR22","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1523-1755.2005.00603.x","volume":"68","author":"G Coen","year":"2005","unstructured":"Coen G, Mantella D, Manni M, Balducci A, Nofroni I, Sardella D, et al. 25-Hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int. 2005;68(4):1840\u20138.","journal-title":"Kidney Int."},{"key":"9071_CR23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","volume":"51","author":"J Gogusev","year":"1997","unstructured":"Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E, et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 1997;51:328\u201336.","journal-title":"Kidney Int."},{"key":"9071_CR24","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","volume":"92","author":"N Fukuda","year":"1993","unstructured":"Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest. 1993;92:1436\u201343.","journal-title":"J Clin Invest."},{"issue":"3","key":"9071_CR25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1172\/JCI11895","volume":"108","author":"F Schaefer","year":"2001","unstructured":"Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R. Impaired jak-stat signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest. 2001;108(3):467\u201375.","journal-title":"J Clin Invest."},{"issue":"3","key":"9071_CR26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1210\/endo.138.3.4977","volume":"128","author":"B Tonshoff","year":"1997","unstructured":"Tonshoff B, Powell DR, Zhao D, Durham SK, Coleman ME, Domene HM, et al. Decreased hepatic insulin-like growth factor (IGF)- I and increased igf binding protein-1 and -2 gene expression in experimental uremia. Endocrinology 1997;128(3):938\u201346.","journal-title":"Endocrinology"},{"key":"9071_CR27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1994.31","volume":"45","author":"IB Salusky","year":"1994","unstructured":"Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD. Kidney Int. 1994;45:253\u20138.","journal-title":"Kidney Int."},{"issue":"6","key":"9071_CR28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ki.1982.107","volume":"21","author":"E Hodson","year":"1982","unstructured":"Hodson E, Evans R, Dunstan C, Hills E, Shaw P. Quantitative bone histology in children with chronic renal failure. Kidney Int. 1982;21(6):833\u20139.","journal-title":"Kidney Int."},{"issue":"6","key":"9071_CR29","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ndt\/gfg116","volume":"18","author":"GB Spasovski","year":"2003","unstructured":"Spasovski GB, Bervoets ARJ, Behets GJS, Ivanovski N, Sikole A, Dams G. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transplant. 2003;18(6):1159\u201366.","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"9071_CR30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/089686080602600112","volume":"26","author":"M Avila-Diaz","year":"2006","unstructured":"Avila-Diaz M, Matos M, Garcia-Lopez E, Prado M-d-C, Castro-Vazquez F, Ventura MDJ, et al. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis. Perit Dial Int. 2006;26(1):78\u201384.","journal-title":"Perit Dial Int."},{"key":"9071_CR31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","volume":"53","author":"BD Kuizon","year":"1998","unstructured":"Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, et al. Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int. 1998;53:205\u201311.","journal-title":"Kidney Int."},{"issue":"2","key":"9071_CR32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","volume":"58","author":"E Slatopolsky","year":"2000","unstructured":"Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, et al. A novel mechanism for skeletal resistance in uremia. Kidney Int. 2000;58(2):753\u201361.","journal-title":"Kidney Int."},{"key":"9071_CR33","first-page":"145","volume":"75","author":"LD Quarles","year":"1992","unstructured":"Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab. 1992;75:145\u201350.","journal-title":"J Clin Endocrinol Metab."},{"key":"9071_CR34","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2003.00915.x","volume":"63","author":"IB Salusky","year":"2003","unstructured":"Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, et al. Similar predictive value of bone turnover using the first- and second-generation immunometric Pth assays in pediatric patients treated with peritoneal dialysis. Kidney Int. 2003;63:1801\u20138.","journal-title":"Kidney Int."},{"issue":"4","key":"9071_CR35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/ncpneph0443","volume":"3","author":"JD Hernandez","year":"2007","unstructured":"Hernandez JD, Wesseling K, Boechat M, Gales B, Salusky IB. Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol. Nat Clin Pract Nephrol. 2007;3(4):227\u201332.","journal-title":"Nat Clin Pract Nephrol."},{"issue":"7","key":"9071_CR36","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/ndt\/gfl098","volume":"21","author":"S Briese","year":"2006","unstructured":"Briese S, Wiesner S, Will J, Lembcke A, Opgen-Rhein B, Nissel R, et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease\u2013impact of calcium and vitamin D therapy. Nephrol Dial Transplant. 2006;21(7):1906\u201314.","journal-title":"Nephrol Dial Transplant."},{"issue":"20","key":"9071_CR37","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon B, Yoon C, Gales B, Sider D, et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Eng J Med. 2000;342(20):1478\u201383.","journal-title":"N Eng J Med."},{"issue":"6","key":"9071_CR38","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/j.1523-1755.2005.00345.x","volume":"67","author":"P Stenvinkel","year":"2005","unstructured":"Stenvinkel P, Wang K, Qureshi A, Axelsson J, Pecoits-Filho R, Gao P, et al. Low fetuin-a levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 2005;67(6):2383\u201392.","journal-title":"Kidney Int."},{"issue":"6","key":"9071_CR39","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/01.ASN.0000068404.57780.DD","volume":"14","author":"MR Davies","year":"2003","unstructured":"Davies MR, Lund RJ, Hruska KA. Bmp-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol. 2003;14(6):1559\u201367.","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"9071_CR40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","volume":"61","author":"SM Moe","year":"2002","unstructured":"Moe SM, O, Neill KD, Duan D, Ahmed S, Chen NX, et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002;61(2):638\u201348.","journal-title":"Kidney Int"},{"key":"9071_CR41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s004670000557","volume":"16","author":"MM Mitsnefes","year":"2001","unstructured":"Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF. Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol. 2001;16:318\u201323.","journal-title":"Pediatr Nephrol."},{"issue":"5","key":"9071_CR42","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1681\/ASN.2004110932","volume":"16","author":"M Litwin","year":"2005","unstructured":"Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol. 2005;16(5):1494\u2013500.","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"9071_CR43","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5414\/CNP62432","volume":"62","author":"R Lobao","year":"2004","unstructured":"Lobao R, Carvalho A, Cuppari L, Ventura R, Lazaretti-Castro M, Jorgetti V, et al. High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: Bone histomorphometric analysis. Clin Nephrol. 2004;62(6):432\u20139.","journal-title":"Clin Nephrol."},{"issue":"10","key":"9071_CR44","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00467-007-0546-7","volume":"22","author":"M Andrade","year":"2007","unstructured":"Andrade M, Carvalhaes L, Carvalho A, Lazaretti-Castro M, Brandao C. Bone mineral density and bone histomorphometry in children on long-term dialysis. Pediatr Nephrol. 2007;22(10):1767\u201372.","journal-title":"Pediatr Nephrol."},{"issue":"3","key":"9071_CR45","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","volume":"56","author":"M Rix","year":"1999","unstructured":"Rix M, Andreassen H, Eskildsen P, Lagdahl B, Olgaard K. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int. 1999;56(3):1084\u201393.","journal-title":"Kidney Int."},{"key":"9071_CR46","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"Jadoul M, Albert J, Akiba T, Akizawa T, Arab L, Bragg-Gresham J, et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int. 2006;70:1358\u201366.","journal-title":"Kidney Int."},{"issue":"6","key":"9071_CR47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","volume":"36","author":"M Coco","year":"2000","unstructured":"Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000;36(6):1115\u201321.","journal-title":"Am J Kidney Dis."},{"key":"9071_CR48","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00467-002-1041-9","volume":"18","author":"EM Lima","year":"2003","unstructured":"Lima EM, Goodman WG, Kuizon BD, Gales B, Emerick A, Goldin J, et al. Bone density measurements in pediatric patients with renal osteodystrophy. Pediatr Nephrol. 2003;18:554\u20139.","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"9071_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jmri.20085","volume":"20","author":"F Wehrli","year":"2004","unstructured":"Wehrli F, Leonard M, Saha P, Gomberg B. Quantitative high-resolution magnetic resonance imaging reveals structural implications of renal osteodystrophy on trabecular and cortical bone. J Magn Reson Imag. 2004;20(1):83\u201389.","journal-title":"J Magn Reson Imag."},{"issue":"2","key":"9071_CR50","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.rct.0000238007.19258.3d","volume":"31","author":"T Hopper","year":"2007","unstructured":"Hopper T, Wehrli FW, Saha P, Andre J, Wright A, Sanchez C, et al. Quantitative microcomputed tomography assessment of intratrabecular, intertrabecular, and cortical bone architecture in a rat model of severe renal osteodystrophy. J Comput Assist Tomography 2007;31(2):320\u20138.","journal-title":"J Comput Assist Tomography"},{"issue":"6","key":"9071_CR51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00467-006-0048-z","volume":"21","author":"D Hothi","year":"2006","unstructured":"Hothi D, Harvey E, Piva E, Keating L, Secker D, Geary D. Calcium and phosphate balance in adolescents on home nocturnal haemodialysis. Pediatr Nephrol. 2006;21(6):835\u201341.","journal-title":"Pediatr Nephrol."},{"key":"9071_CR52","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/ki.1997.218","volume":"51","author":"WG Goodman","year":"1997","unstructured":"Goodman WG, Veldhuis JD, Belin TR, Juppner H, Salusky IB. Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism. Kidney Int. 1997;51:1590\u20135.","journal-title":"Kidney Int."},{"issue":"4","key":"9071_CR53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/j.ajkd.2005.12.039","volume":"47","author":"A Pieper","year":"2006","unstructured":"Pieper A, Haffner D, Hoppe B, Dittrich K, Offner G, Bonzel K-E, et al. A randomized crossover trial comparing sevelamer with calcium acetate in children with Ckd. Am J Kidney Dis. 2006;47(4):625\u201335.","journal-title":"Am J Kidney Dis."},{"issue":"12","key":"9071_CR54","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00467-003-1298-7","volume":"18","author":"H Mahdavi","year":"2003","unstructured":"Mahdavi H, Kuizon B, Gales B, Wang H, Elashoff R, Salusky IB. Sevelamer hydrochloride: An effective phosphate binder in dialyzed children. Pediatr Nephrol. 2003;18(12):1260\u20134.","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"9071_CR55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1681\/ASN.2006050490","volume":"18","author":"S Mathew","year":"2007","unstructured":"Mathew S, Lund RJ, Strebeck F, Tustison KS, Geurs T, Hruska KA. Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol. 2007;18(1):122\u201330.","journal-title":"J Am Soc Nephrol."},{"issue":"S90","key":"9071_CR56","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1111\/j.1523-1755.2004.09007.x","volume":"66","author":"B Brezina","year":"2004","unstructured":"Brezina B, Qunibi WY, Nolan CR. Acid loading during treatment with sevelamer hydrochloride: Mechanisms and clinical implications. Kidney Int. 2004;66(S90):S39\u2013S45.","journal-title":"Kidney Int."},{"issue":"6","key":"9071_CR57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bone.2005.11.022","volume":"38","author":"AR Bervoets","year":"2006","unstructured":"Bervoets AR, Oste L, Behets GJ, Dams G, Blust R, Marynissen R, et al. Development and reversibility of impaired mineralization associated with lanthanum carbonate treatment in chronic renal failure rats. Bone 2006;38(6):803\u201310.","journal-title":"Bone"},{"issue":"6","key":"9071_CR58","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/j.1523-1755.2005.00753.x","volume":"68","author":"E Slatopolsky","year":"2005","unstructured":"Slatopolsky E, Liapis H, Finch J. Progressive accumulation of lanthanum in the liver of normal and uremic rats. Kidney Int. 2005;68(6):2809\u201313.","journal-title":"Kidney Int."},{"issue":"5","key":"9071_CR59","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.ki.5002375","volume":"72","author":"C Sanchez","year":"2007","unstructured":"Sanchez C, He Y. Bone growth during daily or intermittent calcitriol treatment during renal failure with advanced secondary hyperparathyroidism. Kidney Int. 2007;72(5):582\u201391.","journal-title":"Kidney Int."},{"issue":"5","key":"9071_CR60","first-page":"1190","volume":"77","author":"S Scharla","year":"1993","unstructured":"Scharla S, Strong D, Rosen C, Mohan S, Holick M, Baylink D, et al. 1,25-Dihydroxyvitamin D3 increases Secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in Vivo. J Clin Endocrinol Metab. 1993;77(5):1190\u20137.","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"9071_CR61","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","volume":"72","author":"M Mizobuchi","year":"2007","unstructured":"Mizobuchi M, Finch JL, Martin DR, Slatopolsky E. Differential effects of vitamin d receptor activators on vascular calcification in uremic rats. Kidney Int. 2007;72(6):709\u201315.","journal-title":"Kidney Int."},{"issue":"5","key":"9071_CR62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5414\/CNP65335","volume":"65","author":"H Joist","year":"2006","unstructured":"Joist H, Ahya S, Giles K, Norwood K, Slatopolsky E, Coyne D. Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients. Clin Nephrol. 2006;65(5):335\u201341.","journal-title":"Clin Nephrol."},{"issue":"5 Suppl 5","key":"9071_CR63","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ajkd.2001.28110","volume":"38","author":"SM Sprague","year":"2001","unstructured":"Sprague SM, Lerma E, McCormmick D, Abraham M, Batlle D. Suppression of parathyroid hormone secretion in hemodialysis patients: Comparison of paricalcitol with calcitriol. Am J Kidney Dis. 2001;38(5 Suppl 5):S51\u2013S56.","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"9071_CR64","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1053\/j.ajkd.2007.03.008","volume":"49","author":"L Greenbaum","year":"2007","unstructured":"Greenbaum L, Benador N, Goldstein S, Paredes A, Melnick J, Mattingly S, et al. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis. Am J Kidney Dis. 2007;49(6):814\u201323.","journal-title":"Am J Kidney Dis."},{"issue":"10","key":"9071_CR65","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00467-006-0204-5","volume":"21","author":"W Seeherunvong","year":"2006","unstructured":"Seeherunvong W, Nwobi O, Abitbol C, Chandar J, Strauss J, Zilleruelo G. Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol. 2006;21(10):1434\u20139.","journal-title":"Pediatr Nephrol."},{"issue":"4","key":"9071_CR66","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/089686080502500411","volume":"25","author":"N Shah","year":"2005","unstructured":"Shah N, Bernardini J, Piraino B. Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int. 2005;25(4):362\u20136.","journal-title":"Perit Dial Int."},{"issue":"5","key":"9071_CR67","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/07315724.2007.10719637","volume":"26","author":"F Tylavsky","year":"2007","unstructured":"Tylavsky F, Ryder K, Li R, Park V, Womack C, Norwood J, et al. Preliminary findings: 25(OH)D levels and PTH are indicators of rapid bone accrual in pubertal children. J Am Coll Nutr. 2007;26(5):462\u201370.","journal-title":"J Am Coll Nutr."},{"issue":"3","key":"9071_CR68","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/ajcn\/78.3.485","volume":"78","author":"S Cheng","year":"2003","unstructured":"Cheng S, Tylavsky F, Kroger H, Karkkainen M, Lyytikainen A, Koistinen A, et al. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr. 2003;78(3):485\u201392.","journal-title":"Am J Clin Nutr."},{"issue":"15","key":"9071_CR69","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco ALM, Turner SA, Avram MM, Suranyi MG, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350(15):1516\u201325.","journal-title":"N Engl J Med."},{"issue":"4","key":"9071_CR70","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","volume":"68","author":"J Cunningham","year":"2005","unstructured":"Cunningham J, Danese M, Olson K, Klassen P, Chertow GM. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int. 2005;68(4):1793\u2013800.","journal-title":"Kidney Int."},{"issue":"1","key":"9071_CR71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1096\/fj.03-0294fje","volume":"18","author":"S Wu","year":"2004","unstructured":"Wu S, Palese T, Mishra O, Delivoria-Papadopoulos M, Luca FD. Effects of Ca2+-sensing receptor activation in the growth plate. FASEB J. 2004;18(1):143\u20135.","journal-title":"FASEB J."},{"key":"9071_CR72","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","volume":"111","author":"L Zeitlin","year":"2003","unstructured":"Zeitlin L, Rauch F, Plotkin H, Glorieux FH. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatr. 2003;111:1030\u20136.","journal-title":"Pediatr."},{"issue":"2","key":"9071_CR73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2005-2036","volume":"91","author":"F Rauch","year":"2006","unstructured":"Rauch F, Travers R, Glorieux FH. Pamidronate in children with osteogenesis imperfecta: Histomorphometric effects of long-term therapy. J Clin Endocrinol Metab. 2006;91(2):511\u20136.","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-007-9071-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-007-9071-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-007-9071-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T09:02:43Z","timestamp":1588237363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-007-9071-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,4]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9071"],"URL":"https:\/\/doi.org\/10.1007\/s11154-007-9071-z","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,4]]}}}